Pharmaceuticals

Global COVID19 Diagnostic Testing Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-18814187 | Published Date: 29-Jul-2021 | No. of pages: 119

Description

The COVID19 Diagnostic Testing market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global COVID19 Diagnostic Testing market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the COVID19 Diagnostic Testing Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in COVID19 Diagnostic Testing market are:
Danaher
bioMérieux SA
Quidel Corporation
Cepheid
Thermo Fisher Scientific, Inc.
1drop Inc.
F. Hoffman-La Roche Ltd.
Abbott
Luminex Corporation
ALDATU BIOSCIENCES
ADT Biotech Sdn Bhd
Bio-Rad
Veredus Laboratories
Mylab Discovery Solutions Pvt Ltd.
Neuberg Diagnostics
Perkin Elmer, Inc.
Laboratory Corporation of America Holdings
Hologic Inc.
Quest Diagnostics
altona Diagnostics GmbH

Most important types of COVID19 Diagnostic Testing products covered in this report are:
Polymerase Chain Reaction (PCR)
Antibody or Enzyme-Linked Immunosorbent Assay (ELISA)
Serology
Portable or Point-of-Care (POC)
Others

Most widely used downstream fields of COVID19 Diagnostic Testing market covered in this report are:
Laboratories
Hospitals
Diagnostic Centers and Clinics
Research Institutes

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.